Early urinary catheter removal for Urinary Retention

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Atrium Health, Charlotte, NC
Urinary Retention+1 More
Early urinary catheter removal - Other
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This study aims to investigate whether patients who self-remove their indwelling transurethral catheters on POD 1 have similar rates of postoperative catheter reinsertion for urinary retention (within the first 7 days after surgery) compared with those who undergo catheter self-removal on POD 3.

Eligible Conditions

  • Urinary Retention

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Urinary Retention

Study Objectives

1 Primary · 7 Secondary · Reporting Duration: 30 days

30 days
Number of visits
Prolonged catheterization
Readmission rates
Urinary tract infection rate
7 days
Number of patient phone calls
Percentage of patients requiring re-insertion of a transurethral urinary catheter
Short Term Catheter Burden Questionnaire
Urinary Force of stream

Trial Safety

Safety Progress

1 of 3

Other trials for Urinary Retention

Trial Design

2 Treatment Groups

(Standard practice group): self-removal of transurethral catheter on POD 3
1 of 2
(Intervention group): self-removal of transurethral catheter on POD 1
1 of 2
Active Control
Experimental Treatment

104 Total Participants · 2 Treatment Groups

Primary Treatment: Early urinary catheter removal · No Placebo Group · N/A

(Intervention group): self-removal of transurethral catheter on POD 1
Other
Experimental Group · 1 Intervention: Early urinary catheter removal · Intervention Types: Other
(Standard practice group): self-removal of transurethral catheter on POD 3
Other
ActiveComparator Group · 1 Intervention: Urinary catheter removal on POD 3 · Intervention Types: Other

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 30 days
Closest Location: Atrium Health · Charlotte, NC
Photo of charlotte 1Photo of charlotte 2Photo of charlotte 3
2022First Recorded Clinical Trial
2 TrialsResearching Urinary Retention
17 CompletedClinical Trials

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor
1,099 Previous Clinical Trials
1,128,915 Total Patients Enrolled
2 Trials studying Urinary Retention
228 Patients Enrolled for Urinary Retention
Megan TarrPrincipal InvestigatorWake Forest University Health Sciences

Eligibility Criteria

Age 18+ · Female Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.